The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 14, 2010
Filed:
Mar. 31, 2003
Vishwa Nath Gupta, Jammu, IN;
Krishan Avtar Suri, Jammu, IN;
Bishan Datt Gupta, Jammu, IN;
Bupinder Singh Jaggi, Jammu, IN;
Naresh Kumar Satti, Jammu, IN;
Bal Krishan Chandan, Jammu, IN;
Neelam Sharma, Jammu, IN;
Vikram Bhardwaj, Jammu, IN;
OM Parkash Suri, Jammu, IN;
Ghulam Nabi Qazi, Jammu, IN;
Jyotsna Suri, Jammu, IN;
Madalsa Bargotra, Jammu, IN;
Vishwa Nath Gupta, Jammu, IN;
Krishan Avtar Suri, Jammu, IN;
Bishan Datt Gupta, Jammu, IN;
Bupinder Singh Jaggi, Jammu, IN;
Naresh Kumar Satti, Jammu, IN;
Bal Krishan Chandan, Jammu, IN;
Neelam Sharma, Jammu, IN;
Vikram Bhardwaj, Jammu, IN;
Om Parkash Suri, Jammu, IN;
Ghulam Nabi Qazi, Jammu, IN;
Jyotsna Suri, Jammu, IN;
Madalsa Bargotra, Jammu, IN;
Council of Scientific and Industrial Research, New Delhi, IN;
Abstract
The present invention relates to a synergistic formulation comprising trans-tetracos-15-enoic acid (t-TCA) and andrographolide (AP) in the ratio ranging between 1:7 to 7:1 (w/w), useful in hepatoprotection; and a process for the preparation of a synergistic formulation comprising trans-tetracos-15-enoic acid (t-TCA) and andrographolide (AP) useful in hepatoprotection, said process comprising steps of grounding the particles of the t-TCA and AP into fine particles, mixing the fine particles in ratio ranging between 1:7 to 7:1 (w/w), and grinding the mixture to obtain formulation, and also, a method of hepatoprotection of a subject using the synergistic formulation comprising trans-tetracos-15-enoic acid (t-TCA) and andrographolide (AP), said method comprising the steps of administering the formulation to the subject.